Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingo Tamm

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Clinical Science (London, England : 1979)|March 11, 2006
Antisense therapy in malignant diseases: status quo and quo vadis?Ingo Tamm
Current Opinion in Investigational Drugs (London, England : 2000)|June 3, 2008
AEG-35156, an antisense oligonucleotide against X-linked inhibitor of apoptosis for the potential treatment of cancerIngo Tamm
Molecular Biotechnology|September 2, 2006
Antisense therapy in clinical oncology: preclinical and clinical experiencesIngo Tamm, Mandy Wagner
Annals of Hematology|September 30, 2005
Decitabine activates specific caspases downstream of p73 in myeloid leukemiaIngo Tamm, Mandy Wagner, Karin Schmelz
International Journal of Cancer|November 22, 2007
Transcriptional regulation of human survivin by early growth response (Egr)-1 transcription factorMandy Wagner, Karin Schmelz, Bernd Dörken, et al.
Leukemia Research|January 22, 2008
Epigenetic and genetic analysis of the survivin promoter in acute myeloid leukemiaMandy Wagner, Karin Schmelz, Bernd Dörken, et al.
International Journal of Cancer|December 21, 2004
5-Aza-2'-deoxycytidine induces p21WAF expression by demethylation of p73 leading to p53-independent apoptosis in myeloid leukemiaKarin Schmelz, Mandy Wagner, Bernd Dörken, et al.
International Journal of Cancer|April 19, 2006
In vivo expression of survivin and its splice variant survivin-2B: impact on clinical outcome in acute myeloid leukemiaMandy Wagner, Karin Schmelz, Christian Wuchter, et al.
Haematologica|March 17, 2004
Differences in the expression pattern of apoptosis-related molecules between childhood and adult de novo acute myeloid leukemiaChristian Wuchter, Stephan Richter, Doreen Oltersdorf, et al.
Progress in Brain Research|July 25, 2007
The effect of induced hyperthermia on the immune systemAnnette Dieing, Olaf Ahlers, Bert Hildebrandt, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Clinical Science (London, England : 1979)|March 11, 2006
Antisense therapy in malignant diseases: status quo and quo vadis?Ingo Tamm
Current Opinion in Investigational Drugs (London, England : 2000)|June 3, 2008
AEG-35156, an antisense oligonucleotide against X-linked inhibitor of apoptosis for the potential treatment of cancerIngo Tamm
Molecular Biotechnology|September 2, 2006
Antisense therapy in clinical oncology: preclinical and clinical experiencesIngo Tamm, Mandy Wagner
Annals of Hematology|September 30, 2005
Decitabine activates specific caspases downstream of p73 in myeloid leukemiaIngo Tamm, Mandy Wagner, Karin Schmelz
International Journal of Cancer|November 22, 2007
Transcriptional regulation of human survivin by early growth response (Egr)-1 transcription factorMandy Wagner, Karin Schmelz, Bernd Dörken, et al.
Leukemia Research|January 22, 2008
Epigenetic and genetic analysis of the survivin promoter in acute myeloid leukemiaMandy Wagner, Karin Schmelz, Bernd Dörken, et al.
International Journal of Cancer|December 21, 2004
5-Aza-2'-deoxycytidine induces p21WAF expression by demethylation of p73 leading to p53-independent apoptosis in myeloid leukemiaKarin Schmelz, Mandy Wagner, Bernd Dörken, et al.
International Journal of Cancer|April 19, 2006
In vivo expression of survivin and its splice variant survivin-2B: impact on clinical outcome in acute myeloid leukemiaMandy Wagner, Karin Schmelz, Christian Wuchter, et al.
Haematologica|March 17, 2004
Differences in the expression pattern of apoptosis-related molecules between childhood and adult de novo acute myeloid leukemiaChristian Wuchter, Stephan Richter, Doreen Oltersdorf, et al.
Progress in Brain Research|July 25, 2007
The effect of induced hyperthermia on the immune systemAnnette Dieing, Olaf Ahlers, Bert Hildebrandt, et al.
Pageof 2